60 DEGREES PHARMACEUTICALS, INC. Research And Development Expense

Quick Answer

60 DEGREES PHARMACEUTICALS, INC. reported Research And Development Expense of $2.11 million for the year ending 2025.

  • 60 DEGREES PHARMACEUTICALS, INC. showed a decrease of -57.8% in Research And Development Expense from 2024 to 2025.
  • This data is from 60 DEGREES PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), 60 DEGREES PHARMACEUTICALS, INC.'s Research And Development Expense has grown by 300.7%.
  • Historical annual values: Fiscal year 2025: $2.11 million | Fiscal year 2024: $4.99 million | Fiscal year 2023: $691.8 thousand | Fiscal year 2022: $525.6 thousand.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: